Scilex Holding Company
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SCLX research report →
About the company
Scilex Holding Company is a biopharmaceutical enterprise that specializes in the development and market introduction of non-opioid therapies designed to alleviate both acute and chronic pain. Its primary marketed offering is ZTlido 1. 8%, a topical prescription formulation of lidocaine specifically engineered to mitigate neuropathic discomfort associated with post-herpetic neuralgia, a condition characterized by persistent nerve pain following shingles.
- CEO
- Henry H. Ji
- IPO
- 2021
- Employees
- 115
- HQ
- Palo Alto, CA, US
Price Chart
- Market Cap
- $66.32M
- P/E
- -0.20
- P/S
- 1.96
- P/B
- -0.22
- EV/EBITDA
- -0.45
- Div Yield
- 0.00%
- Gross Margin
- 54.96%
- Op Margin
- -817.05%
- Net Margin
- -1239.37%
- ROE
- 190.13%
- ROIC
- 230.47%
- Revenue
- $30.25M · -46.54%
- Net Income
- $-358,734,000 · -392.72%
- EPS
- $-36.48 · -87.75%
- Op Income
- $-272,304,000
- FCF YoY
- -80.36%
- 52W High
- $21.34
- 52W Low
- $2.62
- 50D MA
- $5.33
- 200D MA
- $7.65
- Beta
- 1.73
- Avg Volume
- 134.41K
Get TickerSpark's AI analysis on SCLX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 17, 26 | Ma Stephen Hoi | buy | 650,000 |
| Apr 16, 26 | Ji Henry | buy | 3,250,000 |
| Apr 17, 26 | Ji Henry | sell | 650,000 |
| Dec 26, 25 | Scilex Holding Co | sell | 3,689,016 |
| Dec 29, 25 | Scilex Holding Co | sell | 7,310,984 |
| Dec 30, 25 | Scilex Holding Co | sell | 9,657,300 |
| Oct 8, 25 | Wu Yue Alexander | other | 20,000 |
| Oct 8, 25 | Ma Stephen Hoi | other | 60,000 |
| Oct 8, 25 | Chun Jay | other | 20,000 |
| Oct 8, 25 | Ji Henry | other | 120,000 |
Our SCLX coverage
Recent articles, reports, and earnings notes.
No research on SCLX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SCLX report →Similar companies
Peers in the same neighborhood.